172 related articles for article (PubMed ID: 35029076)
1. Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.
Hwang JA; Min JH; Kim SH; Choi SY; Lee JE; Moon JY
Korean J Radiol; 2022 Apr; 23(4):389-401. PubMed ID: 35029076
[TBL] [Abstract][Full Text] [Related]
2. Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.
Aslan S; Eryuruk U; Tasdemir MN; Cakir IM
Abdom Radiol (NY); 2022 Jul; 47(7):2325-2334. PubMed ID: 35672474
[TBL] [Abstract][Full Text] [Related]
3. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
Lee HJ; Hong SB; Lee NK; Kim S; Seo HI; Kim DU; Han SY; Choo KS
Eur Radiol; 2021 Nov; 31(11):8606-8614. PubMed ID: 33881570
[TBL] [Abstract][Full Text] [Related]
4. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.
Ryeom H; Chang Y; Park SY; Cho SH; Yeo B; Je H; Baek J
Medicine (Baltimore); 2023 Nov; 102(46):e36176. PubMed ID: 37986292
[TBL] [Abstract][Full Text] [Related]
6. Total Bilirubin Levels as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer: Correspondence.
Sookaromdee P; Wiwanitkit V
Korean J Radiol; 2022 Apr; 23(4):491. PubMed ID: 35289153
[No Abstract] [Full Text] [Related]
7. Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase?
Kobi M; Paroder V; Flusberg M; Rozenblit AM; Chernyak V
Clin Radiol; 2017 Jan; 72(1):55-62. PubMed ID: 27842889
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
[TBL] [Abstract][Full Text] [Related]
10. Predicting Patients With Insufficient Liver Enhancement in the Hepatobiliary Phase Before the Injection of Gadoxetic Acid: A Practical Approach Using the Bayesian Method.
Mori Y; Motosugi U; Shimizu T; Ichikawa S; Kromrey ML; Onishi H
J Magn Reson Imaging; 2020 Jan; 51(1):62-69. PubMed ID: 31016840
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression.
Elkilany A; Geisel D; Müller T; Fischer A; Denecke T
Abdom Radiol (NY); 2021 Mar; 46(3):979-991. PubMed ID: 32918576
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
15. Effect of type 2 diabetes on liver images of GD-EOB-DTPA-enhanced MRI during the hepatobiliary phase.
Zhang WY; Sun HY; Zhang WL; Feng R
Sci Rep; 2023 Jan; 13(1):543. PubMed ID: 36631556
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.
Koh J; Chung YE; Nahm JH; Kim HY; Kim KS; Park YN; Kim MJ; Choi JY
Eur Radiol; 2016 Feb; 26(2):407-16. PubMed ID: 26002136
[TBL] [Abstract][Full Text] [Related]
17. Inter-reader reliability of functional liver imaging score derived from gadoxetic acid-enhanced MRI: a meta-analysis.
Kim NH; Kang JH
Abdom Radiol (NY); 2023 Mar; 48(3):886-894. PubMed ID: 36576517
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.
Chang AI; Kim YK; Min JH; Lee J; Kim H; Lee SJ
Abdom Radiol (NY); 2019 Apr; 44(4):1395-1406. PubMed ID: 30515535
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
